EditorialEditorial
The role of DLL1 in long-term vascular normalization and cancer immunotherapy
Qiaozhen Wu and Yuhui Huang
Cancer Biology & Medicine November 2021, 18 (4) 940-943; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0507
Qiaozhen Wu
1Suzhou Ninth Hospital Affiliated to Soochow University, Suzhou 215200, China
Yuhui Huang
1Suzhou Ninth Hospital Affiliated to Soochow University, Suzhou 215200, China
2Hematology Center, Cyrus Tang Medical Institute, The Collaborative Innovation Center of Hematology, State Key Laboratory of Radiation Medicine and Protection, Soochow University, Suzhou 215123, China
References
- 1.↵
- Bagchi S,
- Yuan R,
- Engleman E.
- 2.↵
- Munn L,
- Jain R.
- 3.↵
- 4.↵
- 5.↵
- Jain R.
- 6.↵
- Goruganthu M,
- Shanker A,
- Dikov M,
- Carbone D.
- 7.↵
- Ridgway J,
- Zhang G,
- Wu Y,
- Stawicki S,
- Liang W,
- Chanthery Y, et al.
- 8.↵
- Yan M,
- Callahan C,
- Beyer J,
- Allamneni K,
- Zhang G,
- Ridgway J, et al.
- 9.↵
- Zhang N,
- Yin R,
- Zhou P,
- Liu X,
- Fan P,
- Qian L, et al.
- 10.↵
- Tchekneva E,
- Goruganthu M,
- Uzhachenko R,
- Thomas P,
- Antonucci A,
- Chekneva I, et al.
- 11.↵
- Jain R.
- 12.↵
In this issue
The role of DLL1 in long-term vascular normalization and cancer immunotherapy
Qiaozhen Wu, Yuhui Huang
Cancer Biology & Medicine Nov 2021, 18 (4) 940-943; DOI: 10.20892/j.issn.2095-3941.2021.0507
Related Articles
- No related articles found.
Cited By...
- No citing articles found.